Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Treatment
New findings from Germany, France and Israel in the area of cancer treatment detailed
May 10th, 2006
Data on cancer treatment are outlined in reports from Germany, France and Israel. Study 1: Vaccination with altered peptide ligand-loaded dendritic cells induced cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors. According to recent research published in the journal Cancer Immunology Immunotherapy, "Dendritic cells (DCs) are characterized by their extraordinary capacity to induce T-cell responses, providing the opportunity of DC-based cancer vaccination protocols. In the present study, we conducted a phase I/II clinical trial to determine the capability of DCs differentiated from immunomagnetically...
Source: Vaccine Weekly (2006-05-10)
|
